{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:54:57Z","timestamp":1789170897052,"version":"build-2803163510"},"reference-count":51,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p><jats:bold>Background<\/jats:bold> Nasal polyposis occurs frequently in patients with intrinsic asthma, especially in those who are aspirin sensitive. It can be difficult to treat effectively, even with surgery and regular topical intranasal corticosteroids many patients are still symptomatic.<\/jats:p><jats:p><jats:bold>Objective<\/jats:bold> To investigate the response to montelukast, a leukotriene D<jats:sub>4<\/jats:sub> receptor antagonist, as an add\u2010on therapy to topical and inhaled corticosteroids in patients, both aspirin sensitive (AS) and aspirin tolerant (AT), with nasal polyposis and asthma.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> Nasal polyposis symptoms were assessed by visual analogue scales; nasal polyps were assessed by nasendoscopy and via the measurement of nasal volumes by acoustic rhinometry. The nasal airway was assessed by nasal inspiratory peakflow (NIPF). Asthma was monitored using symptom scores and peak expiratory flow measurements. Aspirin sensitivity was assessed by history together with intranasal lysine aspirin challenge. Upper and lower airway nitric oxide measurements were made before and during treatment.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Clinical subjective improvement in nasal polyposis occurred in 64% AT (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), patients and 50% AS patients (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05); asthma improvement in 87% AT and 61% AS patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05 for both). Objective changes in peak flow occurred only in AT patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Acoustic rhinometry, nasal inspiratory peak flow and nitric oxide levels did not change significantly in any group, however, correlations were seen between nitric oxide levels and polyp scores and between nitric oxide levels and acoustic rhinometry changes. Improvement on montelukast therapy was not associated with any of the following variables: age, sex, skin prick test positivity, disease duration or aspirin sensitivity. (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05 for all).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> The findings are consistent with a subgroup of nasal polyps\/asthma patients in whom leukotriene receptor antagonists are effective. This is not related to aspirin sensitivity. Further placebo\u2010controlled studies need to be undertaken.<\/jats:p>","DOI":"10.1046\/j.1365-2222.2001.01160.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:49:00Z","timestamp":1047358140000},"page":"1385-1391","source":"Crossref","is-referenced-by-count":100,"title":["An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma"],"prefix":"10.1111","volume":"31","author":[{"given":"S.","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. C.","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"Allergic and Non\u2010Allergic Rhinitis.","author":"Drake\u2010Lee AB.","year":"1993"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(77)90171-3"},{"key":"e_1_2_5_4_2","volume-title":"Rhinitis.","author":"Settipane GA.","year":"1991"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(74)90081-5"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(75)90092-5"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065887781693420"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2500\/108854196778662228"},{"key":"e_1_2_5_9_2","volume-title":"Nasal Polyposis. An Inflammatory Disease and its Treatment","author":"Lund VJ.","year":"1997"},{"key":"e_1_2_5_10_2","first-page":"499","volume-title":"New Dimensions in Otorhinolaryngology, Head and Neck Surgery.","author":"Settipane GA","year":"1987"},{"key":"e_1_2_5_11_2","first-page":"33","article-title":"Nasal polyps, state of the art","volume":"11","author":"Settipane GA","year":"1991","journal-title":"Rhinology"},{"key":"e_1_2_5_12_2","first-page":"149","article-title":"Prophylactic treatment with flunisolide after polypectomy","volume":"20","author":"Drettner B","year":"1982","journal-title":"Rhinology"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1975.tb01848.x"},{"key":"e_1_2_5_14_2","first-page":"17","article-title":"Nasal polyps treated by beclomethasone nasal aerosol","volume":"15","author":"Deuschl H","year":"1977","journal-title":"Rhinology"},{"key":"e_1_2_5_15_2","first-page":"9","article-title":"The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy","volume":"18","author":"Virolanen E","year":"1980","journal-title":"Rhinology"},{"key":"e_1_2_5_16_2","first-page":"49","article-title":"Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy","volume":"23","author":"Dingsor G","year":"1985","journal-title":"Rhinology"},{"key":"e_1_2_5_17_2","first-page":"144","article-title":"A randomized trial of intranasal beclomethasone dipropionate after polypectomy","volume":"20","author":"Karlsson G","year":"1982","journal-title":"Rhinology"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70125-8"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90173-5"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI620"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.2.357"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198406213102502"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1986.tb01960.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012203232506"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.6.7767514"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608213150803"},{"key":"e_1_2_5_27_2","first-page":"500","article-title":"Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects","volume":"39","author":"Davidson AB","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_5_28_2","first-page":"S443","article-title":"Pranlukast, an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis","volume":"99","author":"Grossman J","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459989010200303"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90109-7"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91073-U"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90384-2"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1991.tb03199.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90184-3"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7202.87"},{"key":"e_1_2_5_36_2","first-page":"136","article-title":"Asthma controller therapy: role of antileukotrienes, a new therapeutic class","volume":"54","author":"Allegra L","year":"1999","journal-title":"Monaldi Arch Chest Dis"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00005"},{"key":"e_1_2_5_38_2","first-page":"73","article-title":"The use of complementary\/alternative medicine for treatment of asthma in the United States","volume":"2","author":"Dahlan PA","year":"1998","journal-title":"J Invest Allergol Clin Immunol"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70086-6"},{"key":"e_1_2_5_40_2","first-page":"101","article-title":"Acoustic rhinometry compared with anterior rhinomanometry in the assessment of the response of nasal allergen challenge","volume":"6","author":"Scadding GK","year":"1992","journal-title":"Am J Rhinol"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10071683"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/014556139907800818"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.3.8087328"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.4.9105060"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80092-6"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-3-199702010-00001"},{"key":"e_1_2_5_47_2","first-page":"A16","article-title":"Effect of multiple doses of RG 12525, an oral leukotriene D4 antagonist, in chronic asthma","volume":"145","author":"Wahdena I","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.106040"},{"key":"e_1_2_5_49_2","doi-asserted-by":"crossref","unstructured":"WilsonA SimsE OrrLet al.Comparative effects of intranasal mometasone furoate (MF) versus oral montelukast (ML) plus cetirizine (CZ) in seasonal allergic rhinitis. 56th Annual Meeting: American Academy of Allergy Asthma and Immunology San Diego JACI March. Abstract No: 610 2000.","DOI":"10.1016\/S0091-6749(00)91038-8"},{"issue":"615","key":"e_1_2_5_50_2","first-page":"s206","article-title":"Paradoxical low nasal nitric oxide in nasal polyposis","volume":"105","author":"Colantonio D","year":"2000","journal-title":"JACI"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M003490200"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/014556130007900107"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2001.01160.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2001.01160.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.2001.01160.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:49:34Z","timestamp":1697561374000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.2001.01160.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1046\/j.1365-2222.2001.01160.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.2001.01160.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}